INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,013,481 | -30.7% | 4,704,395 | -10.8% | 0.01% | -29.4% |
| Q2 2023 | $2,905,858 | -16.6% | 5,273,789 | 0.0% | 0.02% | -10.5% |
| Q1 2023 | $3,484,920 | +4.9% | 5,273,789 | 0.0% | 0.02% | -5.0% |
| Q4 2022 | $3,322,487 | -82.4% | 5,273,789 | +35.4% | 0.02% | -83.7% |
| Q3 2022 | $18,846,000 | +4.8% | 3,893,700 | 0.0% | 0.12% | +20.6% |
| Q2 2022 | $17,989,000 | -57.0% | 3,893,700 | 0.0% | 0.10% | -57.7% |
| Q1 2022 | $41,857,000 | -37.2% | 3,893,700 | 0.0% | 0.24% | -25.6% |
| Q4 2021 | $66,621,000 | -4.3% | 3,893,700 | 0.0% | 0.32% | +5.9% |
| Q3 2021 | $69,600,000 | -7.5% | 3,893,700 | 0.0% | 0.31% | -7.3% |
| Q2 2021 | $75,226,000 | -23.0% | 3,893,700 | 0.0% | 0.33% | -22.0% |
| Q1 2021 | $97,654,000 | – | 3,893,700 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |